Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,938.00    36.00 (1.89%)
Bid:
1,938.50
Ask:
1,939.50
Spread: 1.00 (0.052%)
Market Cap: £77.72b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

GSK submits bepirovirsen for EMA review after trials hit primary endpoints
27 Mar 2026

GSK submits bepirovirsen for EMA review after trials hit primary endpoints

(Sharecast News) - Drugmaker GSK said on Friday that the European Medicines Agency will review its marketing authorisation application for the use of ...

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review
27 Mar 2026

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regu...

WINNERS & LOSERS: Next climbs; Ceres jumps on Centrica deal
26 Mar 2026

WINNERS & LOSERS: Next climbs; Ceres jumps on Centrica deal

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.

LONDON MARKET CLOSE: FTSE 100 climbs on Middle East peace deal hopes
25 Mar 2026

LONDON MARKET CLOSE: FTSE 100 climbs on Middle East peace deal hopes

(Alliance News) - Stocks rallied on Wednesday, and oil prices cooled, on hopes for an end to the conflict in the Middle East despite Iran reportedly r...

DIRECTOR DEALINGS: GSK, Smiths Group and Savills directors buys shares
24 Mar 2026

DIRECTOR DEALINGS: GSK, Smiths Group and Savills directors buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and no...

GSK's lung cancer treatment secures "orphan drug" status in Japan
23 Mar 2026

GSK's lung cancer treatment secures "orphan drug" status in Japan

(Alliance News) - GSK PLC on Monday said Japanese health authorities had granted "orphan drug" status to its lung cancer treatment.

London open: Stocks tumble as Middle East conflict escalates
23 Mar 2026

London open: Stocks tumble as Middle East conflict escalates

(Sharecast News) - A GSK treatment for an aggressive form of small-cell lung cancer has been granted orphan drug designation in Japan, the pharma blue...

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich
23 Mar 2026

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its r...